{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T13:48:26Z","timestamp":1782049706222,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,21]]},"DOI":"10.7759\/cureus.111231","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T13:42:31Z","timestamp":1782049351000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Serum Lipocalin-2 in Type 2 Diabetes Mellitus Patients With and Without Retinopathy"],"prefix":"10.7759","author":[{"given":"Sanaur","family":"Naz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhipuram Periyasamy","family":"Senthilkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin Elizabeth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Panneerselvam Anandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Babu K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115734","article-title":"Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments","volume":"168","author":"Antar SA","year":"2023","unstructured":"Antar SA, Ashour NA, Sharaky M, et al.. Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother. 2023, 168:115734. 10.1016\/j.biopha.2023.115734","journal-title":"Biomed Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy","volume":"2007","author":"Kowluru RA","year":"2007","unstructured":"Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007, 2007:43603. 10.1155\/2007\/43603","journal-title":"Exp Diabetes Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-024-03015-x","article-title":"Review of lipocalin-2-mediated effects in diabetic retinopathy","volume":"44","author":"Zhang Y","year":"2024","unstructured":"Zhang Y, Song X, Qi T, Zhou X. Review of lipocalin-2-mediated effects in diabetic retinopathy. Int Ophthalmol. 2024, 44:78. 10.1007\/s10792-024-03015-x","journal-title":"Int Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03423-8","article-title":"The role of lipocalin-2 in age-related macular degeneration (AMD)","volume":"77","author":"Ghosh S","year":"2020","unstructured":"Ghosh S, Stepicheva N, Yazdankhah M, et al.. The role of lipocalin-2 in age-related macular degeneration (AMD). Cell Mol Life Sci. 2020, 77:835-51. 10.1007\/s00018-019-03423-8","journal-title":"Cell Mol Life Sci"},{"key":"ref5","unstructured":"National ethical guidelines for biomedical and health research involving human participants\r\n. (2017). Accessed. 2026: https:\/\/ethics.ncdirindia.org\/asset\/pdf\/ICMR_National_Ethical_Guidelines.pdf."},{"key":"ref6","unstructured":"International clinical classification system for diabetic retinopathy and diabetic macular edema. (2012). Accessed. 2026: https:\/\/www.aao.org\/education\/clinical-statement\/international-clinical-classification-system-diabe."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2024.102989","article-title":"Revised definition of obesity in Asian Indians living in India","volume":"19","author":"Misra A","year":"2025","unstructured":"Misra A, Vikram NK, Ghosh A, Ranjan P, Gulati S. Revised definition of obesity in Asian Indians living in India. Diabetes Metab Syndr. 2025, 19:102989. 10.1016\/j.dsx.2024.102989","journal-title":"Diabetes Metab Syndr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-023-03365-y","article-title":"Association between lipocalin-2 levels and diabetic retinopathy in patients with overweight\/obese type 2 diabetes mellitus","volume":"192","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Song X, Qi T, Gao S, Sun C, Yang J, Zhou X. Association between lipocalin-2 levels and diabetic retinopathy in patients with overweight\/obese type 2 diabetes mellitus. Ir J Med Sci. 2023, 192:2785-92. 10.1007\/s11845-023-03365-y","journal-title":"Ir J Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82053-2","article-title":"Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population","volume":"11","author":"Lee J","year":"2021","unstructured":"Lee J, Kim B, Kim W, et al.. Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population. Sci Rep. 2021, 11:2366. 10.1038\/s41598-021-82053-2","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23395","article-title":"Role of lipid indices in the assessment of microvascular risk in type 2 diabetic retinopathy patients","volume":"14","author":"Namitha D","year":"2022","unstructured":"Namitha D, Nusrath A, Asha Rani N, Dhananjaya SY, Lokanathan TH, Kruthi BN, Vijay Kumar AG. Role of lipid indices in the assessment of microvascular risk in type 2 diabetic retinopathy patients. Cureus. 2022, 14:e23395. 10.7759\/cureus.23395","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13141","article-title":"Plasma neutrophil gelatinase-associated lipocalin levels are positively associated with diabetic retinopathy in patients with type\u00a02 diabetes","volume":"33","author":"Chung JO","year":"2016","unstructured":"Chung JO, Park SY, Cho DH, Chung DJ, Chung MY. Plasma neutrophil gelatinase-associated lipocalin levels are positively associated with diabetic retinopathy in patients with type\u00a02 diabetes. Diabet Med. 2016, 33:1649-54. 10.1111\/dme.13141","journal-title":"Diabet Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-11","article-title":"Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people","volume":"11","author":"Huang Y","year":"2012","unstructured":"Huang Y, Yang Z, Ye Z, et al.. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people. Cardiovasc Diabetol. 2012, 11:11. 10.1186\/1475-2840-11-11","journal-title":"Cardiovasc Diabetol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108450","article-title":"Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: a fenofibrate Intervention and event lowering in diabetes sub-study","volume":"169","author":"Ong KL","year":"2020","unstructured":"Ong KL, Wu L, Januszewski AS, et al.. Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: a fenofibrate Intervention and event lowering in diabetes sub-study. Diabetes Res Clin Pract. 2020, 169:108450. 10.1016\/j.diabres.2020.108450","journal-title":"Diabetes Res Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(02)00710-4","article-title":"An iron delivery pathway mediated by a lipocalin","volume":"10","author":"Yang J","year":"2002","unstructured":"Yang J, Goetz D, Li JY, et al.. An iron delivery pathway mediated by a lipocalin. Mol Cell. 2002, 10:1045-56. 10.1016\/s1097-2765(02)00710-4","journal-title":"Mol Cell"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116586","article-title":"CRISPR\/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells","volume":"231","author":"Rahimi S","year":"2019","unstructured":"Rahimi S, Roushandeh AM, Ebrahimi A, Samadani AA, Kuwahara Y, Roudkenar MH. CRISPR\/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells. Life Sci. 2019, 231:116586. 10.1016\/j.lfs.2019.116586","journal-title":"Life Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang W","year":"2018","unstructured":"Wang W, Lo AC. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018, 19:1816. 10.3390\/ijms19061816","journal-title":"Int J Mol Sci"},{"key":"ref17","article-title":"TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations","volume":"15","author":"Joussen AM","year":"2009","unstructured":"Joussen AM, Doehmen S, Le ML, et al.. TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis. 2009, 15:1418-28.","journal-title":"Mol Vis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/629529","article-title":"TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy","volume":"2013","author":"Costagliola C","year":"2013","unstructured":"Costagliola C, Romano V, De Tollis M, et al.. TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm. 2013, 2013:629529. 10.1155\/2013\/629529","journal-title":"Mediators Inflamm"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.10.040","article-title":"Systemic soluble tumor necrosis factor receptors 1 and 2 are associated with severity of diabetic retinopathy in Hispanics","volume":"119","author":"Kuo JZ","year":"2012","unstructured":"Kuo JZ, Guo X, Klein R, et al.. Systemic soluble tumor necrosis factor receptors 1 and 2 are associated with severity of diabetic retinopathy in Hispanics. Ophthalmology. 2012, 119:1041-6. 10.1016\/j.ophtha.2011.10.040","journal-title":"Ophthalmology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02353-x","article-title":"Nitric oxide and TNF-\u03b1 are correlates of diabetic retinopathy independent of hs-CRP and HbA1c","volume":"69","author":"Khaloo P","year":"2020","unstructured":"Khaloo P, Qahremani R, Rabizadeh S, et al.. Nitric oxide and TNF-\u03b1 are correlates of diabetic retinopathy independent of hs-CRP and HbA1c. Endocrine. 2020, 69:536-41. 10.1007\/s12020-020-02353-x","journal-title":"Endocrine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1541","article-title":"Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity","volume":"59","author":"Law IK","year":"2010","unstructured":"Law IK, Xu A, Lam KS, et al.. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes. 2010, 59:872-82. 10.2337\/db09-1541","journal-title":"Diabetes"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0352-z","article-title":"Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea","volume":"33","author":"Hwang IC","year":"2019","unstructured":"Hwang IC, Bae JH, Kim JM. Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea. Eye (Lond). 2019, 33:980-7. 10.1038\/s41433-019-0352-z","journal-title":"Eye (Lond)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.8.1320","article-title":"Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study","volume":"25","author":"van Leiden HA","year":"2002","unstructured":"van Leiden HA, Dekker JM, Moll AC, et al.. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care. 2002, 25:1320-5. 10.2337\/diacare.25.8.1320","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/502839-assessment-of-serum-lipocalin-2-in-type-2-diabetes-mellitus-patients-with-and-without-retinopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T13:42:33Z","timestamp":1782049353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/502839-assessment-of-serum-lipocalin-2-in-type-2-diabetes-mellitus-patients-with-and-without-retinopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.111231","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,21]]}}}